Investigational Site Number 643007

Kazan' 420077

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis Relapse, Neuropathic Pain

Studies at this site

• Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain — Completed
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early